101
Views
6
CrossRef citations to date
0
Altmetric
Review

Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics

, , , &
Pages 399-409 | Published online: 12 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Supriya Dabir, Mohan Rajan, Liji Parasseril, Vaidehi Bhatt, Preetam Samant, C A B Webers & T T J M Berendschot. (2021) Early Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography. Clinical Ophthalmology 15, pages 331-339.
Read now
Shuang Jiang & Xiaolong Chen. (2017) HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo. Drug Design, Development and Therapy 11, pages 783-795.
Read now
Salman Sarwar, Mostafa Hanout, Mohammad Ali Sadiq, Mohamed K Soliman, Aniruddha Agarwal, Diana V Do & Quan Dong Nguyen. (2015) The role of ranibizumab in the management of diabetic retinopathy. Expert Review of Ophthalmology 10:4, pages 329-340.
Read now

Articles from other publishers (3)

Stephen H. Sinclair, Elan Miller, Kiran S. Talekar & Stanley S. Schwartz. (2022) Diabetes mellitus associated neurovascular lesions in the retina and brain: A review. Frontiers in Ophthalmology 2.
Crossref
Nathan R. Haines, Niranjan Manoharan, Jeffrey L. Olson, Angelo D’Alessandro & Julie A. Reisz. (2018) Metabolomics Analysis of Human Vitreous in Diabetic Retinopathy and Rhegmatogenous Retinal Detachment. Journal of Proteome Research 17:7, pages 2421-2427.
Crossref
Xiang Ren, Chen Li, Junli Liu, Chenghong Zhang, Yuzhen Fu, Nina Wang, Haiying Ma, Heyuan Lu, Hui Kong & Li Kong. (2017) Thioredoxin plays a key role in retinal neuropathy prior to endothelial damage in diabetic mice. Oncotarget 8:37, pages 61350-61364.
Crossref